Stock Events

Stock Events

BioGaia 

$11.79
10
+$1.37+13.17% Monday 20:00

Statistics

Day High
10.42
Day Low
10.42
52W High
11.94
52W Low
9.58
Volume
1,000
Avg. Volume
117
Mkt Cap
0
P/E Ratio
31.58
Dividend Yield
1.7%
Dividend
0.2

Upcoming

11
MAY
Dividend Ex
Estimated
 
15
MAY
Dividend Payment
Estimated
 
10
MAY 27
Dividend Ex
Estimated
 
14
MAY 27
Dividend Payment
Estimated
 
9
MAY 28
Dividend Ex
Estimated
 

Dividends

1.7%Dividend Yield
May 25
$0.2
May 25
$0.51
May 24
$0.18
May 24
$0.46
May 23
$0.14
10Y Growth
3.03%
5Y Growth
4.1%
3Y Growth
12.06%
1Y Growth
N/A

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.05
0.07
0.09
0.11
Expected EPS
0.087612
Actual EPS
N/A

Financials

24.78%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
129.76MRevenue
32.15MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLAF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Daiichi Sankyo.
DSKYF
Mkt Cap44.13B
Danisco (DuPont Nutrition & Biosciences) offers probiotic strains that compete directly with BioGaia's products in the dietary supplement market.
Chervon Limited
CHRHF
Mkt Cap1.33B
Chr. Hansen Holding A/S specializes in probiotic and natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries, directly competing with BioGaia's probiotic offerings.
Novonesis AS
NVZMY
Mkt Cap27.97B
Novozymes provides bioinnovation, including probiotics that can be used in various applications, competing in the same space as BioGaia.
Kerry Group
KRYAF
Mkt Cap15.09B
Kerry Group offers nutritional and functional ingredients, including probiotics, that compete with BioGaia's range of products.
Herbalife
HLF
Mkt Cap824.85M
Herbalife Nutrition offers dietary supplements, including probiotics, competing in the same market as BioGaia.
Nusatrip
NUTR
Mkt Cap0
Nutraceutical International Corporation manufactures and markets nutritional supplements, including probiotics, directly competing with BioGaia.
Amarin
AMRN
Mkt Cap338.71M
Amarin Corporation focuses on cardiovascular health products, but its interest in overall health could lead to expansion into areas like probiotics, making it a potential competitor to BioGaia.

About

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.
Show more...
CEO
Ms. Theresa P. Agnew
Country
SE
ISIN
SE0017769995

Listings

OTC Link
US
BIOGY
F
DE
BGLA.F
ST
SE
BIOG-B.ST
OTC Link
US
BGLAF

0 Comments

Share your thoughts

FAQ

What is BioGaia stock price today?▼
The current price of BGLAF is $11.79 USD — it has increased by +13.17% in the past 24 hours. Watch BioGaia stock price performance more closely on the chart.
What is BioGaia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioGaia stocks are traded under the ticker BGLAF.
When is the next BioGaia earnings date?▼
BioGaia is going to release the next earnings report on May 07, 2026.
What were BioGaia earnings last quarter?▼
BGLAF earnings for the last quarter are 0.11 USD per share, whereas the estimation was 0.09 USD resulting in a +22.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioGaia revenue for the last year?▼
BioGaia revenue for the last year amounts to 129.76M USD.
What is BioGaia net income for the last year?▼
BGLAF net income for the last year is 32.15M USD.
Does BioGaia pay dividends?▼
Yes, BGLAF dividends are paid annual. The last dividend per share was 0.2 USD. As of today, Dividend Yield (FWD)% is 1.7%.
When did BioGaia complete a stock split?▼
The last stock split for BioGaia was on May 26, 2022 with a ratio of 2.5:1.
Where is BioGaia headquartered?▼
BioGaia is headquartered in Stockholm, SE.